Patents

Topical Lotion for Acne Vulgaris Contains Tazarotene

Bausch Health Ireland has patented this treatment that contains tazarotene or tazarotenic acid salt.

Photo: Korneliia Lutso/Shutterstock.com

Photo: Korneliia Lutso/Shutterstock.com

US Patent No. 12,128,137 B2 (Arturo Angel, Radhakrishnan Pillai); Bausch Health Ireland, Dublin, has patented a method of treating acne vulgaris. The method entails topical application of a pharmaceutical lotion composition (oil-in-water emulsion) that consists of tazarotene or a pharmaceutically acceptable tazarotenic acid salt, a liquid oil component, and an aqueous component.

The tazarotene or tazarotenic acid salt is dissolved in the liquid oil component.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters